Immunogen (IMGN) Remains Neutral Rated at UBS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Immunogen (IMGN) Remains Neutral Rated at UBS

Immunogen, Inc. (IMGN) Misses Q4 EPS by 51c

August 1, 2014 6:34 AM EDT

Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.83), $0.51 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $5.74 million versus the consensus estimate of $9.72 million.

For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.

... More